Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 30% ± 9% | |
glutamatergic neuron | 6 studies | 38% ± 24% | |
astrocyte | 5 studies | 29% ± 11% | |
oligodendrocyte | 5 studies | 24% ± 6% | |
microglial cell | 4 studies | 20% ± 5% | |
epithelial cell | 4 studies | 30% ± 10% | |
GABAergic neuron | 4 studies | 40% ± 19% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 9% | |
interneuron | 4 studies | 42% ± 25% | |
GABAergic interneuron | 3 studies | 19% ± 2% | |
myeloid cell | 3 studies | 16% ± 0% | |
retinal cone cell | 3 studies | 20% ± 1% | |
lymphocyte | 3 studies | 20% ± 2% | |
abnormal cell | 3 studies | 31% ± 11% | |
fibroblast | 3 studies | 24% ± 9% | |
macrophage | 3 studies | 22% ± 7% | |
transit amplifying cell | 3 studies | 24% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2893.88 | 1445 / 1445 | 100% | 31.64 | 183 / 183 |
intestine | 100% | 2901.72 | 966 / 966 | 100% | 17.05 | 527 / 527 |
ovary | 100% | 3588.68 | 180 / 180 | 100% | 22.87 | 430 / 430 |
skin | 100% | 3349.48 | 1809 / 1809 | 100% | 29.81 | 472 / 472 |
uterus | 100% | 3348.36 | 170 / 170 | 100% | 14.87 | 459 / 459 |
prostate | 100% | 3109.27 | 245 / 245 | 100% | 16.53 | 501 / 502 |
thymus | 100% | 3171.45 | 653 / 653 | 100% | 14.63 | 603 / 605 |
stomach | 100% | 2460.43 | 359 / 359 | 100% | 20.15 | 285 / 286 |
lung | 100% | 2778.40 | 578 / 578 | 99% | 20.03 | 1149 / 1155 |
pancreas | 100% | 1738.28 | 328 / 328 | 99% | 12.59 | 177 / 178 |
breast | 100% | 3160.11 | 459 / 459 | 99% | 16.94 | 1111 / 1118 |
brain | 99% | 2247.84 | 2623 / 2642 | 100% | 23.67 | 705 / 705 |
bladder | 100% | 3071.05 | 21 / 21 | 99% | 15.02 | 500 / 504 |
kidney | 100% | 2301.70 | 89 / 89 | 99% | 16.39 | 893 / 901 |
adrenal gland | 100% | 3002.68 | 258 / 258 | 99% | 11.76 | 227 / 230 |
liver | 100% | 1584.82 | 226 / 226 | 98% | 8.90 | 397 / 406 |
adipose | 100% | 3189.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2685.47 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 18.33 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.75 | 29 / 29 |
muscle | 100% | 2056.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3520.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.54 | 1 / 1 |
heart | 99% | 1641.69 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2380.56 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006405 | Biological process | RNA export from nucleus |
GO_0006606 | Biological process | protein import into nucleus |
GO_0051028 | Biological process | mRNA transport |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005643 | Cellular component | nuclear pore |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008139 | Molecular function | nuclear localization sequence binding |
GO_0017056 | Molecular function | structural constituent of nuclear pore |
GO_0005515 | Molecular function | protein binding |
Gene name | POM121C |
Protein name | Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C) POM121 transmembrane nucleoporin C POM121C protein |
Synonyms | |
Description | FUNCTION: Essential component of the nuclear pore complex (NPC). The repeat-containing domain may be involved in anchoring components of the pore complex to the pore membrane. When overexpressed in cells induces the formation of cytoplasmic annulate lamellae (AL). . |
Accessions | C9JFL1 ENST00000615331.5 [A8CG34-2] A8CG34 A8MY32 ENST00000398379.2 ENST00000607367.5 [A8CG34-1] ENST00000439629.2 A1L4L9 |